Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonmyeloablative alternative donor transplants.
Luznik L, O'Donnell PV, Fuchs EJ. Luznik L, et al. Curr Opin Oncol. 2003 Mar;15(2):121-6. doi: 10.1097/00001622-200303000-00001. Curr Opin Oncol. 2003. PMID: 12601275 Review.
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Huff CA, Fuchs EJ, Smith BD, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH, Vogelsang GB, Griffin CA, Luznik L, Jones RJ. Huff CA, et al. Among authors: luznik l. Biol Blood Marrow Transplant. 2006 Apr;12(4):414-21. doi: 10.1016/j.bbmt.2005.11.520. Biol Blood Marrow Transplant. 2006. PMID: 16545725 Free article. Clinical Trial.
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, Hess AD, Vogelsang GB. Bolaños-Meade J, et al. Among authors: luznik l. Biol Blood Marrow Transplant. 2007 Oct;13(10):1185-91. doi: 10.1016/j.bbmt.2007.06.011. Epub 2007 Aug 3. Biol Blood Marrow Transplant. 2007. PMID: 17889355 Free PMC article. Clinical Trial.
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA, Luznik L, Matsui W, Ambinder R, Jones RJ, Smith BD. Warlick ED, et al. Among authors: luznik l. Leuk Res. 2008 Sep;32(9):1439-47. doi: 10.1016/j.leukres.2007.12.017. Epub 2008 Feb 7. Leuk Res. 2008. PMID: 18261793 Free PMC article.
167 results